Cargando…

Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide

Detalles Bibliográficos
Autores principales: Varela, Daniel L., Ayinapudi, Karnika, Ahmed, Bilal, Groh, Christopher A., Freedman, Roger A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811113/
https://www.ncbi.nlm.nih.gov/pubmed/36620369
http://dx.doi.org/10.1016/j.hrcr.2022.09.011
_version_ 1784863461155536896
author Varela, Daniel L.
Ayinapudi, Karnika
Ahmed, Bilal
Groh, Christopher A.
Freedman, Roger A.
author_facet Varela, Daniel L.
Ayinapudi, Karnika
Ahmed, Bilal
Groh, Christopher A.
Freedman, Roger A.
author_sort Varela, Daniel L.
collection PubMed
description
format Online
Article
Text
id pubmed-9811113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98111132023-01-05 Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide Varela, Daniel L. Ayinapudi, Karnika Ahmed, Bilal Groh, Christopher A. Freedman, Roger A. HeartRhythm Case Rep Case Report Elsevier 2022-09-24 /pmc/articles/PMC9811113/ /pubmed/36620369 http://dx.doi.org/10.1016/j.hrcr.2022.09.011 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Varela, Daniel L.
Ayinapudi, Karnika
Ahmed, Bilal
Groh, Christopher A.
Freedman, Roger A.
Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide
title Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide
title_full Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide
title_fullStr Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide
title_full_unstemmed Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide
title_short Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide
title_sort increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811113/
https://www.ncbi.nlm.nih.gov/pubmed/36620369
http://dx.doi.org/10.1016/j.hrcr.2022.09.011
work_keys_str_mv AT vareladaniell increasingpacemakerleadimpedanceandpacingthresholdafterinitiationofchemotherapywithdoxorubicinandcyclophosphamide
AT ayinapudikarnika increasingpacemakerleadimpedanceandpacingthresholdafterinitiationofchemotherapywithdoxorubicinandcyclophosphamide
AT ahmedbilal increasingpacemakerleadimpedanceandpacingthresholdafterinitiationofchemotherapywithdoxorubicinandcyclophosphamide
AT grohchristophera increasingpacemakerleadimpedanceandpacingthresholdafterinitiationofchemotherapywithdoxorubicinandcyclophosphamide
AT freedmanrogera increasingpacemakerleadimpedanceandpacingthresholdafterinitiationofchemotherapywithdoxorubicinandcyclophosphamide